MASLD Follows Daily Rhythm Driven by Nighttime Insulin Resistance
New research reveals fatty liver disease follows circadian patterns linked to insulin resistance and reduced nighttime insulin availability.
4695 articles
New research reveals fatty liver disease follows circadian patterns linked to insulin resistance and reduced nighttime insulin availability.
FDA approves Foundayo (orforglipron) and Zepbound (tirzepatide) for chronic weight management in adults with obesity or overweight conditions.

Bryan Johnson discusses a significant development in his anti-aging Blueprint protocol journey.
Novel p75 neurotrophin receptor fusion protein reduces knee pain by up to 43% compared to placebo in 518-patient randomized trial.
Large randomized trial tests whether deferring coronary stents during TAVI procedures is safe and effective for heart patients.
Decade-long trial reveals new insights on post-stent medication strategies beyond traditional aspirin therapy.
Women experiencing early menopause face significantly higher cardiovascular disease risk, according to new research published in JAMA.
Trastuzumab deruxtecan demonstrates potential benefits in treating residual HER2-positive early breast cancer patients.
Analysis reveals gap in podcast coverage of cellular senescence despite growing research interest in this aging mechanism.

Dr. William Li discusses specific foods that may support cellular repair and potentially slow aging processes through dietary intervention.
Recent podcasts explore how gut bacteria influence sleep, hormones, metabolism, and lifespan extension through emerging therapeutic approaches.

Discover the hidden gut microbiome imbalances that could be driving inflammation, brain fog, and metabolic dysfunction.